AI-03 Efficacy and safety of intermittent 2-deoxyglucose therapy in mouse models of lupus

John Wilson; Thomas J Sproule; Porcia Manandhar; Elisabeth Marnik; Laurence Morel; Derry C Roopenian

doi:10.1136/lupus-2018-lsm.3

Article info

PDF

Adaptive Immunity

AI-03 Efficacy and safety of intermittent 2-deoxyglucose therapy in mouse models of lupus

Free

Authors

John Wilson 1The Jackson Laboratory, Bar Harbor, ME, USA PubMed articles Google scholar articles
Thomas J Sproule 1The Jackson Laboratory, Bar Harbor, ME, USA PubMed articles Google scholar articles
Porcia Manandhar 1The Jackson Laboratory, Bar Harbor, ME, USA PubMed articles Google scholar articles
Elisabeth Marnik 1The Jackson Laboratory, Bar Harbor, ME, USA PubMed articles Google scholar articles
Laurence Morel 2Department of Pathology, University of Florida, Gainesville, FL, USA PubMed articles Google scholar articles
Derry C Roopenian 1The Jackson Laboratory, Bar Harbor, ME, USA PubMed articles Google scholar articles

Citation

Wilson J, Sproule TJ, Manandhar P, et al

AI-03 Efficacy and safety of intermittent 2-deoxyglucose therapy in mouse models of lupus

Lupus Science & Medicine 2018;5:doi: 10.1136/lupus-2018-lsm.3

Publication history

First published September 4, 2018.

Online issue publication

May 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password